Trident Lifeline is currently trading at Rs. 321.00, up by 3.00 points or 0.94% from its previous closing of Rs. 318.00 on the BSE.
The scrip opened at Rs. 304.00 and has touched a high and low of Rs. 321.00 and Rs. 302.55 respectively. So far 45000 shares were traded on the counter.
The BSE group 'MT' stock of face value Rs. 10 has touched a 52 week high of Rs. 339.00 on 05-Sep-2024 and a 52 week low of Rs. 136.00 on 19-Mar-2024.
Last one week high and low of the scrip stood at Rs. 332.00 and Rs. 302.55 respectively. The current market cap of the company is Rs. 369.12 crore.
The promoters holding in the company stood at 65.51%, while Institutions and Non-Institutions held 6.02% and 28.47% respectively.
Trident Lifeline has successfully commenced commercial production at new manufacturing plant situated at Talangpor, Chorasi, Surat, Gujarat with effect from September 12, 2024. The New Manufacturing unit installed with manufacturing capacity of 50,000 Syrup Bottle and 50,000 Ointments per day.
Trident Lifeline is engaged in the manufacturing and marketing of quality finished dosages.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |